Search Results

Filter
  • 1-10 of  98,220 results for ""Psilocybin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.

  • Authors : Rucker J; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Butler M

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/administration & dosage ; Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/adverse effects

  • Source: Headache [Headache] 2024 Nov-Dec; Vol. 64 (10), pp. 1309-1317. Date of Electronic Publication: 2024 Sep 20.Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.

  • Authors : Rakoczy RJ; Department of Psychology, Miami University, Oxford, Ohio, USA.; Runge GN

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/analogs & derivatives ; Tryptamines*/Tryptamines*/Tryptamines*/pharmacology

  • Source: British journal of pharmacology [Br J Pharmacol] 2024 Oct; Vol. 181 (19), pp. 3627-3641. Date of Electronic Publication: 2024 Jun 02.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

Record details

×
Academic Journal

Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.

  • Authors : Reid MJ; Behavioral Sleep Medicine Research Laboratory, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, 5510 Nathan Shock Drive, Suite 100, Baltimore, MD, 21224, USA. .; Johns Hopkins Precision Medicine Center of Excellence (PMCoE) for Depression, Johns Hopkins Hospital, Baltimore, MD, USA. .

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/therapeutic use ; Psilocybin*/Psilocybin*/Psilocybin*/pharmacology; Adult

  • Source: Current psychiatry reports [Curr Psychiatry Rep] 2024 Nov; Vol. 26 (11), pp. 659-669. Date of Electronic Publication: 2024 Nov 13.Publisher: Current Science Country of Publication: United States NLM ID: 100888960 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site.

  • Authors : Hudspeth J; Department of Chemistry, Colorado School of Mines, 1500 Illinois Street, Golden, CO, 80401, USA.; Rogge K

Subjects: Catalytic Domain* ; Methyltransferases*/Methyltransferases*/Methyltransferases*/metabolism ; Methyltransferases*/Methyltransferases*/Methyltransferases*/chemistry

  • Source: Chembiochem : a European journal of chemical biology [Chembiochem] 2024 Dec 02; Vol. 25 (23), pp. e202400497. Date of Electronic Publication: 2024 Nov 09.Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.

  • Authors : Marwood L; Compass Pathfinder Ltd. (a Subsidiary of Compass Pathways plc), FORA Soho, 33 Broadwick Street, London, W1F 0DQ, United Kingdom.; Croal M

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/administration & dosage ; Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/Depressive Disorder, Treatment-Resistant*/drug therapy

  • Source: Journal of psychiatric research [J Psychiatr Res] 2024 Dec; Vol. 180, pp. 198-203. Date of Electronic Publication: 2024 Oct 11.Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.

  • Authors : Szpręgiel I; Department of Pharmacology and Brain Biostructure, Unit II, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. .; Bysiek A

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/therapeutic use ; Glutamic Acid*/Glutamic Acid*/Glutamic Acid*/metabolism

  • Source: Pharmacological reports : PR [Pharmacol Rep] 2024 Dec; Vol. 76 (6), pp. 1297-1304. Date of Electronic Publication: 2024 Oct 16.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101234999 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Impact of psilocybin on cognitive function: A systematic review.

  • Authors : Meshkat S; Interventional Psychiatry Program, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Tello-Gerez TJ

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Psilocybin*/Psilocybin*/Psilocybin*/administration & dosage ; Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology

  • Source: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2024 Dec; Vol. 78 (12), pp. 744-764. Date of Electronic Publication: 2024 Oct 01.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex.

  • Authors : Ivan VE; Canadian Center for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, Alberta, Canada.; Tomàs-Cuesta DP

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/pharmacology ; Hallucinogens*/Hallucinogens*/Hallucinogens*/pharmacology ; Neurons*/Neurons*/Neurons*/drug effects

  • Source: The European journal of neuroscience [Eur J Neurosci] 2024 Nov; Vol. 60 (10), pp. 6395-6407. Date of Electronic Publication: 2024 Oct 04.Publisher: Wiley-Blackwell Country of Publication: France NLM ID: 8918110 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice.

  • Authors : Pohořalá V; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Kuchař M

Subjects: Extinction, Psychological*/Extinction, Psychological*/Extinction, Psychological*/drug effects ; Cues* ; Cocaine*/Cocaine*/Cocaine*/pharmacology

  • Source: Neuroscience [Neuroscience] 2024 Nov 01; Vol. 559, pp. 156-165. Date of Electronic Publication: 2024 Sep 03.Publisher: Elsevier Science Country of Publication: United States NLM ID: 7605074 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use.

  • Authors : Card KG; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.; Grewal A

Subjects: Psilocybin*/Psilocybin*/Psilocybin*/administration & dosage ; Hallucinogens*/Hallucinogens*/Hallucinogens*/administration & dosage ; Adverse Childhood Experiences*

  • Source: Journal of psychoactive drugs [J Psychoactive Drugs] 2024 Nov-Dec; Vol. 56 (5), pp. 616-626. Date of Electronic Publication: 2023 Oct 10.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8113536 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  98,220 results for ""Psilocybin""